Radient Pharmaceuticals Corporation fka RXPC

[Gold Seeker]

Living, you did force me to check the Radient financial reports for stock sales in the first quarter of 2011.

Sales from note conversions. 55,505,799 shares

Sales from warrant conversions 15,258,346 shares.

Considering that the total shares OS at the end of the quarter was 109,390,508, the 2010 lenders were selling TONS of stock and all of that would have shown of the SHO list that you referred to because that's how the lenders sell shares from converted notes and warrants.

The 2011 lenders had not even begun to sell at this point because they did not get the S-3 approved and had to wait until Jul to convert and sell under rule 144.

In those first 3 months of 2011, the 2010 lenders diluted the stock by more than 183%. that was absolutely MASSIVE dilution. That alone would have caused the stock to plummet let alone any hit piece from the street.com.